A classifier developed using SVM was able to identify glypican 3-positive HCC (34); one that was based on RF effectively predicted the malignant potential of gastrointestinal stromal tumors (35); and an MLR-based classifier predicted coronavirus disease (COVID)-infected pulmonary lesions (36). This evidence concerns the gene GPC3 and hepatocellular carcinoma.